Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics Shares Outstanding 2010-2024 | NKTR

Nektar Therapeutics shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Nektar Therapeutics Annual Shares Outstanding
(Millions of Shares)
2023 190
2022 187
2021 183
2020 179
2019 175
2018 180
2017 156
2016 140
2015 132
2014 127
2013 116
2012 115
2011 113
2010 94
2009 93
Nektar Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2024-06-30 209
2024-03-31 195
2023-12-31 190
2023-09-30 190
2023-06-30 190
2023-03-31 189
2022-12-31 187
2022-09-30 188
2022-06-30 187
2022-03-31 186
2021-12-31 183
2021-09-30 184
2021-06-30 183
2021-03-31 181
2020-12-31 179
2020-09-30 179
2020-06-30 178
2020-03-31 177
2019-12-31 175
2019-09-30 175
2019-06-30 175
2019-03-31 174
2018-12-31 180
2018-09-30 173
2018-06-30 182
2018-03-31 161
2017-12-31 156
2017-09-30 163
2017-06-30 155
2017-03-31 154
2016-12-31 140
2016-09-30 137
2016-06-30 136
2016-03-31 136
2015-12-31 132
2015-09-30 133
2015-06-30 132
2015-03-31 136
2014-12-31 127
2014-09-30 132
2014-06-30 127
2014-03-31 124
2013-12-31 116
2013-09-30 116
2013-06-30 116
2013-03-31 115
2012-12-31 115
2012-09-30 115
2012-06-30 115
2012-03-31 115
2011-12-31 113
2011-09-30 114
2011-06-30 114
2011-03-31 109
2010-12-31 94
2010-09-30 94
2010-06-30 94
2010-03-31 94
2009-12-31 93
2009-09-30 93
2009-06-30 93
2009-03-31 93
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.197B $0.090B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.017B 30.41
Takeda Pharmaceutical (TAK) Japan $43.337B 9.02
Sandoz Group AG (SDZNY) Switzerland $19.524B 0.00
Merck (MKKGY) Germany $19.470B 17.44
Astellas Pharma (ALPMY) Japan $19.363B 17.83
United Therapeutics (UTHR) United States $16.217B 15.95
Summit Therapeutics (SMMT) United States $13.503B 0.00
Shionogi (SGIOY) Japan $12.119B 11.61
Neurocrine Biosciences (NBIX) United States $11.890B 31.49
Catalent (CTLT) United States $10.727B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.354B 7.19
Orion OYJ (ORINY) Finland $6.653B 18.71
Madrigal Pharmaceuticals (MDGL) United States $6.294B 0.00
Corcept Therapeutics (CORT) United States $5.431B 41.13
Ionis Pharmaceuticals (IONS) United States $5.422B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.075B 0.00
PTC Therapeutics (PTCT) United States $3.026B 0.00
Dyne Therapeutics (DYN) United States $2.889B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.622B 15.69
Catalyst Pharmaceuticals (CPRX) United States $2.457B 11.14
Arrowhead Pharmaceuticals (ARWR) United States $2.309B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.300B 0.00
Soleno Therapeutics (SLNO) United States $2.233B 0.00
Evotec AG (EVO) Germany $1.928B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.813B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.770B 0.00
Xencor (XNCR) United States $1.614B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.456B 0.00
Ocular Therapeutix (OCUL) United States $1.440B 0.00
Harrow (HROW) United States $1.389B 0.00
ARS Pharmaceuticals (SPRY) United States $1.362B 0.00
Indivior (INDV) United States $1.354B 5.52
Guardian Pharmacy Services (GRDN) United States $1.300B 0.00
Cassava Sciences (SAVA) United States $1.295B 0.00
Enliven Therapeutics (ELVN) United States $1.193B 0.00
Ardelyx (ARDX) United States $1.177B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.163B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.050B 0.00
Collegium Pharmaceutical (COLL) United States $0.954B 5.21
Bioventus (BVS) United States $0.912B 28.82
Relay Therapeutics (RLAY) United States $0.854B 0.00
USANA Health Sciences (USNA) United States $0.769B 14.25
Cronos Group (CRON) Canada $0.768B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.674B 0.00
Tourmaline Bio (TRML) United States $0.650B 0.00
Exscientia (EXAI) United Kingdom $0.613B 0.00
Elite Pharmaceuticals (ELTP) United States $0.600B 0.00
Altimmune (ALT) United States $0.541B 0.00
Organogenesis (ORGO) United States $0.512B 0.00
Savara (SVRA) United States $0.511B 0.00
ProKidney (PROK) United States $0.491B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Zevra Therapeutics (ZVRA) United States $0.460B 0.00
OmniAb (OABI) United States $0.458B 0.00
Korro Bio (KRRO) United States $0.446B 0.00
Xeris Biopharma Holdings (XERS) United States $0.435B 0.00
Larimar Therapeutics (LRMR) United States $0.427B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.425B 172.14
Siga Technologies (SIGA) United States $0.424B 4.95
Esperion Therapeutics (ESPR) United States $0.418B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
4D Molecular Therapeutics (FDMT) United States $0.408B 0.00
Verve Therapeutics (VERV) United States $0.406B 0.00
Aquestive Therapeutics (AQST) United States $0.405B 0.00
Akebia Therapeutics (AKBA) United States $0.391B 0.00
Silence Therapeutics (SLN) United Kingdom $0.380B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.326B 0.00
Avita Medical (RCEL) United States $0.313B 0.00
Sage Therapeutics (SAGE) United States $0.312B 0.00
Lyell Immunopharma (LYEL) United States $0.307B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 17.58
Aldeyra Therapeutics (ALDX) United States $0.251B 0.00
Pyxis Oncology (PYXS) United States $0.249B 0.00
Lexeo Therapeutics (LXEO) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.217B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.202B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.202B 0.00
Profound Medical (PROF) Canada $0.198B 0.00
Nanobiotix S.A (NBTX) France $0.185B 0.00
Heron Therapeutics (HRTX) United States $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.174B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
CytoDyn (CYDY) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.146B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Context Therapeutics (CNTX) United States $0.138B 0.00
Avalo Therapeutics (AVTX) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.127B 0.00
Telomir Pharmaceuticals (TELO) United States $0.110B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Century Therapeutics (IPSC) United States $0.104B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.102B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Regulus Therapeutics (RGLS) United States $0.094B 0.00
Arch Biopartners (ACHFF) Canada $0.092B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
CASI Pharmaceuticals (CASI) China $0.082B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.28
ESSA Pharma (EPIX) Canada $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Scienture Holdings (SCNX) United States $0.069B 0.00
Metagenomi (MGX) United States $0.068B 0.00
AlloVir (ALVR) United States $0.066B 0.00
OptiNose (OPTN) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.057B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Protara Therapeutics (TARA) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Unicycive Therapeutics (UNCY) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Carisma Therapeutics (CARM) United States $0.037B 0.00
Citius Pharmaceuticals (CTXR) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
DURECT (DRRX) United States $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Oruka Therapeutics (ORKA) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
SHINECO (SISI) China $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
CERo Therapeutics Holdings (CERO) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.33
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 37.26